HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bartalena, L. Articles by Martino, E. Search for Related Content PubMed Articles by Bartalena, L. Articles by Martino, E.

Cigarette smoking and the thyroid

The effects of smoking on the function of endocrine glands have been investigated extensively but still are to be elucidated fully. It is widely recognized that the most important component of the smoke produced from the burning of tobacco, in terms of endocrine effects, is nicotine. Nicotine acts through the interaction with acetylcholine receptors, but it seems likely that others among the numerous smoke products may somehow influence endocrine homeostasis.

The present paper will focus on the relationship between smoking and variations in thyroid economy or the occurrence of thyroid dysfunction.

Thyroid function: Several studies have been carried out to ascertain whether smoking is associated with variations in thyroid economy. The rationale for these investigations was dictated by the observation that smoking is associated with a decrease in body mass, and, conversely, refrain from smoking is often accompanied by an increase in body mass (1). These changes might be mediated

This article has been cited by other articles:

				T. Ittermann, C. O. Schmidt, A. Kramer, H. Below, U. John, M. Thamm, H. Wallaschofski, and H. Volzke Smoking as a risk factor for thyroid volume progression and incident goiter in a region with improved iodine supply Eur. J. Endocrinol., December 1, 2008; 159(6): 761 - 766. [Abstract] [Full Text] [PDF]

				I. B. Pedersen, P. Laurberg, N. Knudsen, T. Jorgensen, H. Perrild, L. Ovesen, and L. B. Rasmussen Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study Eur. J. Endocrinol., March 1, 2008; 158(3): 367 - 373. [Abstract] [Full Text] [PDF]

				P. S. Hansen, T. H. Brix, T. I. A. Sorensen, K. O. Kyvik, and L. Hegedus Major Genetic Influence on the Regulation of the Pituitary-Thyroid Axis: A Study of Healthy Danish Twins J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1181 - 1187. [Abstract] [Full Text] [PDF]

				M. A. Hernan, M. J. Oleky, and A. Ascherio Cigarette Smoking and Incidence of Multiple Sclerosis Am. J. Epidemiol., July 1, 2001; 154(1): 69 - 74. [Abstract] [Full Text] [PDF]

				A. P. Weetman Graves' Disease N. Engl. J. Med., October 26, 2000; 343(17): 1236 - 1248. [Full Text] [PDF]

				L. Bartalena, A. Pinchera, and C. Marcocci Management of Graves' Ophthalmopathy: Reality and Perspectives Endocr. Rev., April 1, 2000; 21(2): 168 - 199. [Abstract] [Full Text]

				J. L. Keltner Is Graves Ophthalmopathy a Preventable Disease? Arch Ophthalmol, August 1, 1998; 116(8): 1106 - 1107. [Full Text] [PDF]

				L. Bartalena, C. Marcocci, F. Bogazzi, L. Manetti, M. L. Tanda, E. Dell'Unto, G. Bruno-Bossio, M. Nardi, M. P. Bartolomei, A. Lepri, et al. Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy N. Engl. J. Med., January 8, 1998; 338(2): 73 - 78. [Abstract] [Full Text] [PDF]

				L. C. Hofbauer, T. Muhlberg, A. Konig, G. Heufelder, H.-D. Schworm, and A. E. Heufelder Soluble Interleukin-1 Receptor Antagonist Serum Levels in Smokers and Nonsmokers with Graves' Ophthalmopathy Undergoing Orbital Radiotherapy J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2244 - 2247. [Abstract] [Full Text] [PDF]